Sydne Skaer
Family · Great Falls, MTNPI 1033585815
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,529 of the $4,915 with a category attached, or 92.1%. Organon accounts for 93.3% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $3,561, more than ten times the $20 reported in 2021. Among family clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $213.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$5K
- AbbVie$117
- Novo Nordisk$68
- Sanofi Pasteur Inc.$47
- Astellas Pharma US Inc$46
- Galderma Laboratories, L.p.$21
- plus $33 from 2 others
What the payments were for
- Speaking & faculty fees$4,52992%
- Food & beverage$3868%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 9 | $4,584 |
| AbbVie(2 entities) | 6 | $117 |
| Novo Nordisk | 1 | $68 |
| Sanofi Pasteur Inc. | 2 | $47 |
| Astellas Pharma US Inc | 2 | $46 |
| Galderma Laboratories, L.p. | 1 | $21 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$4,465
How this compares
$4,915 in reported general payments places this provider in the 95th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $936 |
| Clobetasol Propionate | 14 | $246 |
| Trivora-28Levonorgestrel/Ethin.Estradiol | 15 | $213 |
| Fluconazole | 14 | $168 |
Paid to pharmacies, not to this prescriber.
Other family in Great Falls
- Amanda MurrayGreat Falls$101K
- Sadra ThomasGreat Falls$7K
- Betsy AkinGreat Falls$6K
- Sarah PackGreat Falls$4K
- Jennalie GuthmillerGreat Falls$4K
- Casey BarkerGreat Falls$3K
- Courtney FordeGreat Falls$3K
- Kelly TimmerGreat Falls$2K
- April ReynoldsGreat Falls$2K
- Deanna BabbGreat Falls$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.